This report focuses on market background of the areas that are covered, including lung, breast, thyroid and blood cancers (specifically leukemia and lymphoma), as well as pre-conception genetic information and prenatal diagnostics.
Included in this Report:
• Cancer diagnostics companies interviewed include: GeneCentric, Veracyte, Adaptive Biotechnologies
• Genetic and prenatal diagnostics research companies including GenePeeks and Verinata Health
• Comprehensive coverage of survey results (n=123) from the various companies and researchers working in molecular diagnostics.
• A company directory which was created for this report. This includes several seasoned and emerging companies, their areas of focus, and the status of their technologies.
For more information and to purchase this Insight Pharma Report, visit: http://www.InsightPharmaReports.com or contact Kerri Kelley at email@example.com or 781-972-1347.
About Insight Pharma Reports
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. http://www.InsightPharmaReports.com
Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/